WASHINGTON--(BUSINESS WIRE)--The third day of the 2011 BIO International Convention, the world’s largest biotechnology event taking place at the Walter E. Washington Convention Center in Washington, D.C., puts special focus on food and agriculture biotechnology advancements to combat worldwide hunger and the promise of sector growth throughout emerging regions that are propelling biotechnology to new heights. In addition, a new diabetes forum will showcase the latest research, patient issues and medical trends in diabetes and juvenile diabetes. Hosted by the Biotechnology Industry Organization, the 2011 BIO International Convention is expected to attract more than 15,000 attendees from 48 states and 65 countries.
-
BIO Press Conference: Unleashing the Promise of Biotechnology
BIO President and CEO Jim Greenwood to unveil legislative and regulatory proposals to reform the investment and regulatory environment for biotech innovation. (2:00 pm – 3:30 pm)
Other Highlights from Today’s Program Include:
-
Diabetes Forum: Emerging Strategies, Challenges and Partnerships
Learn about key developments in Type 1 and Type 2 diabetes, including new trends in research, novel therapies, biomarkers, diagnostics, public health and economic impact. (8:30 am – 6:00 pm) -
Getting a Biotech Crop to Market—How Much, How Long, and What Steps?
This session will examine the time, capital and importance of intellectual property protections required to stimulate business investment in crop biotechnology. (10:00 am – 11:30 am) -
Super Session: Emerging Markets: The Future of Growth for Biologics?
Leading business executives and senior government officials will discuss how emerging markets are shaping businesses and what impact they will have on the future of biotechnology. (10:00 am – 11:30 am) -
Keynote Address: The Future of Healthcare Reform
Featured speakers: BIO’s President and CEO Jim Greenwood; U.S. Senator John Barrasso (R-WY); former U.S. Senator Tom Daschle (D-SD); Governor Howard Dean (Vermont) and Republican political strategist Karl Rove. (12:00 pm – 2:00 pm)
Biotech Humanitarian Award
Immediately preceding the keynote address, BIO will present the Biotech Humanitarian Award to Dr. Paul Offit for his endeavors in developing one of only two rotavirus vaccines.
-
Super Session: Campbell Alliance 2011 Dealmakers’ Intentions
Featured Speaker: Ben Bonifant, Senior Vice President, Practice Area Leader, Campbell Alliance. This session will share new findings, including year-over-year trends and explore what assets are in demand among pharmaceutical companies and how emerging biotech companies can best position themselves to land the next blockbuster deal. (2:00 pm – 3:30 pm) -
Super Session: Worldview 2011: Scientific American’s Regional
Bio-Innovation Scorecard
Scientific American’s 3rd annual report has a special focus this year on the BRIC (Brazil, Russia, India and China) country efforts to build local biotechnology hubs. In addition, the Scorecard will review individual country programs and policies aimed at growing local innovative biotechnology sectors. (3:45 pm – 5:15 pm)
Media registration is open on site today from 7:30 am – 5:30 pm at the Walter E. Washington Convention Center.
The BIO International Convention is the largest global event for the biotechnology industry, offering networking and partnering opportunities with policymakers, scientists, CEOs and newsmakers, and hundreds of sessions covering biotech trends, policy issues and technological innovations. The Convention also features the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For conference agenda and exhibitor information, visit 2011 BIO International Convention.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtech Now, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtech Now.
Be included in official convention coverage: Tag your convention
related content, blog posts, photos and videos with #bio2011
BIO
Business Forum: #bio1x1
BIO Exhibitors: #bioex
Follow
us on Twitter
Listen
to our podcasts
Join
us on Facebook
Connect
with us on LinkedIn
Participate
in our Meet-ups
Visit
our YouTube
Channel
View our photo albums on Flickr